11-1255545-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002458.3(MUC5B):​c.16053C>T​(p.Thr5351Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0118 in 1,479,462 control chromosomes in the GnomAD database, including 411 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 64 hom., cov: 31)
Exomes 𝑓: 0.010 ( 347 hom. )

Consequence

MUC5B
NM_002458.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.21
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 11-1255545-C-T is Benign according to our data. Variant chr11-1255545-C-T is described in ClinVar as [Benign]. Clinvar id is 164006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.21 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0247 (3753/152028) while in subpopulation NFE AF= 0.0324 (2200/67924). AF 95% confidence interval is 0.0313. There are 64 homozygotes in gnomad4. There are 1861 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3753 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.16053C>T p.Thr5351Thr synonymous_variant Exon 37 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.16053C>T p.Thr5351Thr synonymous_variant Exon 37 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84

Frequencies

GnomAD3 genomes
AF:
0.0247
AC:
3754
AN:
151910
Hom.:
64
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0129
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00740
Gnomad ASJ
AF:
0.0285
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00808
Gnomad FIN
AF:
0.0682
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0324
Gnomad OTH
AF:
0.0225
GnomAD3 exomes
AF:
0.0126
AC:
1822
AN:
144344
Hom.:
51
AF XY:
0.0119
AC XY:
918
AN XY:
77120
show subpopulations
Gnomad AFR exome
AF:
0.0123
Gnomad AMR exome
AF:
0.00281
Gnomad ASJ exome
AF:
0.00659
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00266
Gnomad FIN exome
AF:
0.0474
Gnomad NFE exome
AF:
0.0155
Gnomad OTH exome
AF:
0.0127
GnomAD4 exome
AF:
0.0103
AC:
13691
AN:
1327434
Hom.:
347
Cov.:
34
AF XY:
0.0105
AC XY:
6849
AN XY:
652996
show subpopulations
Gnomad4 AFR exome
AF:
0.00525
Gnomad4 AMR exome
AF:
0.00334
Gnomad4 ASJ exome
AF:
0.0165
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00580
Gnomad4 FIN exome
AF:
0.0659
Gnomad4 NFE exome
AF:
0.00869
Gnomad4 OTH exome
AF:
0.0125
GnomAD4 genome
AF:
0.0247
AC:
3753
AN:
152028
Hom.:
64
Cov.:
31
AF XY:
0.0250
AC XY:
1861
AN XY:
74306
show subpopulations
Gnomad4 AFR
AF:
0.0128
Gnomad4 AMR
AF:
0.00739
Gnomad4 ASJ
AF:
0.0285
Gnomad4 EAS
AF:
0.000195
Gnomad4 SAS
AF:
0.00808
Gnomad4 FIN
AF:
0.0682
Gnomad4 NFE
AF:
0.0324
Gnomad4 OTH
AF:
0.0223
Alfa
AF:
0.0187
Hom.:
16
Bravo
AF:
0.0199
Asia WGS
AF:
0.00318
AC:
11
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

MUC5B: BP4, BP7, BS1, BS2 -

not specified Benign:1
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Thr5351Thr in exon 37 of MUC5B: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 2.6% (203/7862) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs117452757). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.55
DANN
Benign
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs117452757; hg19: chr11-1276775; API